As expected, a rapidly increasing expression of the NMD-sensitive SRSF3 transcript was observed after CHX treatment in SF3B1-mutated cells originating from various cancer types (CLL, UM and pancreatic cancer). This evidence concerns the gene SRSF3 and pancreatic neoplasm.